Next Generation Therapies

- to reduce symptoms of mental illness and retrain the brain

Carlos A. Zarate, M.D. - Brain & Behavior Research Expert on Fast-Acting Antidepressants
Carlos A. Zarate, M.D.
September 30, 2016
From The Quarterly, September 2016 “Imagine you had a compound that does what ketamine does, but without its side effects or risk of addiction,” says Carlos A...
Ming-Hu Han, Ph.D. - Brain & Behavior Research expert on depression
Ming-Hu Han, Ph.D.
September 30, 2016
From The Quarterly, September 2016 Researchers have developed a new therapeutic strategy for treating depression. As described in a paper published May 24 in...
Lisa A. Pan, M.D. - Brain & Behavior Research Expert on Depression
Lisa A. Pan, M.D.
September 13, 2016
Researchers have discovered that some people who suffer from major depression may benefit from the diagnosis and treatment of metabolic deficiencies. Metabolic...
Evdokia Anagnostou, M.D. - Brain & Behavior Research Expert on Autism
Evdokia Anagnostou, M.D.
September 09, 2016
Second-generation antipsychotic medications like risperidone (Risperdal) and aripiprazole (Abilify) can help reduce agitation and irritability in children with...
Sarah H. Lisanby, M.D. of the National Institute of Mental Health
Sarah H. Lisanby, M.D.
August 24, 2016
Electroconvulsive therapy (ECT) in combination with antidepressant medication rapidly relieves the symptoms of major depression in older adults, according to a...

Pages

Subscribe to